The attorneys general of California and Arizona on Tuesday announced Democrats' multi-state lawsuit to block the Trump ...
Comprehensive VAX-31 Adult Phase 3 Clinical Program, Finalized in Consultation and Alignment with FDA, Advances with Three Phase 3 Studies Underway to Support Planned BLA Submission ...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will ...
The Well News on MSN
FDA proposes new treatment approval pathway for ultra-rare diseases
WASHINGTON - The Food and Drug Administration on Monday introduced a regulatory pathway aimed at accelerating the development ...
Louisiana Attorney General Liz Murrill will argue in federal court in Lafayette Tuesday for an injunction to stop the FDA's authorization of mail-order abortion drugs.
Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular dystrophyHOPE-3 clinical study report (CSR) submitted to the U.S. Food and Drug ...
UB will will host its annual Rare Disease Day event from 1-5 p.m. on Friday, Feb. 27, in the Jacobs School of Medicine and Biomedical Sciences, 955 Main St., Buffalo.
The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...
The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results